Search - tctmd.com

Displaying 41 - 60 of 796

Sort: Relevancy | Date

News Conference News TCT 2024

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

Michael O'Riordan

November 06, 2024

News Conference News TCT 2024

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Yael L. Maxwell

November 05, 2024

Presentation TCT 2024

Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI

Presenter: Jennifer Rymer

October 29, 2024

Presentation TCT 2024

Antithrombotics: Balancing Ischemia and Bleeding

Presenter: Robert Harrington

October 28, 2024

News Conference News TCT 2024

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Caitlin E. Cox

October 28, 2024

Presentation TCT 2024

Peri-procedural Antithrombotic Management Across Spectrum of CAD Manifestation

Presenter: Marco Valgimigli

October 28, 2024

Presentation TCT 2024

Modulation of Antiplatelet Therapy After PCI

Presenter: Michelle O'Donoghue

October 28, 2024

Presentation TCT 2024

What’s Next in Acute and Chronic Phase Antithrombotic Therapy in ACS

Presenter: C. Michael Gibson

October 28, 2024

Presentation TCT 2024

Case Presentation: STEMI Patient at High-Bleeding Risk

Presenter: Angelo Oliva

October 28, 2024

Presentation TCT 2024

TCT 9: Diagnostic Accuracy of CT-FFR and QFR for Coronary Lesion-Specific Ischemia

Presenter: Haoyu Wu

October 27, 2024

Presentation TCT 2024

TCT 11: Inpatient Outcomes of Non-ST-Elevation Myocardial Infarction Patients on Chronic Anticoagulation: A Nationwide Analysis

Presenter: Ahmed Younes

October 27, 2024

Presentation TCT 2024

TCT 7: Impact of Use of Proton Pump Inhibitor in Patients Taking Clopidogrel: A Meta-Analysis of Randomized Controlled Trials

Presenter: Mobeen Haider

October 27, 2024

Presentation TCT 2024

TCT 664: Simplifying Coronary Revascularization in High Bleeding Risk With SCAD or ACS: Sirolimus-DCB & SAPT

Presenter: Victor Alfonso Jimenez Diaz

October 27, 2024

Presentation TCT 2024

TCT 10: Interference of Fentanyl in the Pharmacodynamics and Pharmacokinetics of Ticagrelor: A Meta-Analysis of Randomized Trials

Presenter: BERNARDO KREMER

October 27, 2024

Presentation TCT 2024

TCT 228: Treatment Modifications in Ticagrelor-Treated Patients: Insights From the FORCE-ACS Registry

Presenter: Niels van der Sangen

October 27, 2024

Presentation TCT 2024

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

Presenter: Mauro Gitto

October 27, 2024

Presentation TCT 2024

TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy

Presenter: Jung-Kyu Han

October 27, 2024

Presentation TCT 2024

TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials

Presenter: KOTARO MIYASHITA

October 27, 2024

Presentation TCT 2024

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

Presenter: Angelo Oliva

October 27, 2024

Presentation TCT 2024

TCT 4: Rationale and Design of the IMODERN STOP-IMH Randomized Trial: The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for STEMI and the Effect on Intramyocardial Haemorrhage

Presenter: Bahram Yosofi

October 27, 2024

Advertisement

Co-STAR Hints That Colchicine May Curb Rhythm Disturbances After TAVI

After TAVI, Single Antiplatelet Better Than Dual: TRITAVI Registry

Beyond Antithrombotics: Lipid-Lowering and Anti-Inflammatory Therapies Post MI

Antithrombotics: Balancing Ischemia and Bleeding

New DanGer Shock Data: Hemodynamics, Renal Dysfunction, and Bleeding

Peri-procedural Antithrombotic Management Across Spectrum of CAD Manifestation

Modulation of Antiplatelet Therapy After PCI

What’s Next in Acute and Chronic Phase Antithrombotic Therapy in ACS

Case Presentation: STEMI Patient at High-Bleeding Risk

TCT 9: Diagnostic Accuracy of CT-FFR and QFR for Coronary Lesion-Specific Ischemia

TCT 11: Inpatient Outcomes of Non-ST-Elevation Myocardial Infarction Patients on Chronic Anticoagulation: A Nationwide Analysis

TCT 7: Impact of Use of Proton Pump Inhibitor in Patients Taking Clopidogrel: A Meta-Analysis of Randomized Controlled Trials

TCT 664: Simplifying Coronary Revascularization in High Bleeding Risk With SCAD or ACS: Sirolimus-DCB & SAPT

TCT 10: Interference of Fentanyl in the Pharmacodynamics and Pharmacokinetics of Ticagrelor: A Meta-Analysis of Randomized Trials

TCT 228: Treatment Modifications in Ticagrelor-Treated Patients: Insights From the FORCE-ACS Registry

TCT 230: Ticagrelor Monotherapy vs. Ticagrelor Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk: A Post-Hoc Analysis of the TWILIGHT Trial

TCT 229: Rebound Phenomenon of Platelet Reactivity After Cessation of Long-term Clopidogrel Therapy

TCT 231: Safety of Aspirin-Free Prasugrel Monotherapy After PCI: Pooled Analysis of Three Months Outcomes in 508 Patients From ASET-I and ASET-Japan Trials

TCT 227: Timing and Indications for Cangrelor Use and Transition Modalities to Oral P2Y12 Inhibitors in Patients Undergoing PCI: Insights From the SMILE Study

TCT 4: Rationale and Design of the IMODERN STOP-IMH Randomized Trial: The Safety of Ticagrelor Monotherapy After Primary Percutaneous Coronary Intervention for STEMI and the Effect on Intramyocardial Haemorrhage

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content